Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |